Clinical Trial Update: Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies [Phase 1]

View source ↗

Summary

This is a Phase 1 dose-escalation and dose-expansion study of tirabrutinib in combination with other targeted therapies for adults with B-cell malignancies; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Malignancies

Drugs mentioned

• Tirabrutinib (tirabrutinib)

Snippet

Sponsor: Gilead Sciences | Conditions: B-cell Malignancies | Phase 1 | Status: TERMINATED | Results posted: 2025-06-17